CSIMarket Company Name, Ticker, Suppliers, else..
 
Immunitybio inc   (IBRX)
Other Ticker:  
 
 

Immunitybio Inc Balance Sheet Annual

IBRX


Select the Financial Report:   Period:   Fiscal Year:




New: More IBRX's historic Annual Balance Sheets >>

IBRX Balance Sheets
(Annual, GAAP in millions $)

 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
ASSETS
Cash & cash equivalent 265.45 104.64 181.10 11.44 15.51
Cash, Cash Eqvivalents Other - - - - -
Marketable Securities, Current SH 1.01 2.54 136.02 54.77 36.14
Cash & Short-term Investments 266.46 107.18 317.12 66.21 51.65
Accounts receivable - - - - -
Other Receivables, Net, Current 2.02 1.89 1.33 - -
Notes Receivable, Current - - - - -
Inventories - - - - -
Other Current Assets - - - 0.00 -
Prepaid Expense And Other Assets Current 25.60 31.50 15.90 9.29 4.11
Total Current Assets 294.08 140.58 334.35 75.50 55.76
Equipment/Property/Plant Net 146.08 143.66 82.86 53.93 60.50
Goodwill net - - - - -
Intangible Assets 17.09 20.00 1.42 - -
Long-term investments 0.89 0.84 0.82 - 1.50
Accounts Receivable, Net, Noncurrent - - - - -
Financial Instruments - - - - -
Tax Assets, Noncurrent - - - - -
Other Assets, Noncurrent 11.00 14.00 15.00 3.00 25.37
Deferred, Prepaid and Other Assets, Noncurrent - - - - -
Discontinued operations, Noncurrent - - - - -
Operating Lease Right Of Use Asset 36.54 45.79 36.30 13.46 -
Equity Securities Without Readily Determinable Fair Value Amount - - - 7.85 -
Total Assets 504.45 362.36 468.91 151.86 143.12
LIABILITIES
Accounts Payable, Current AC 9.20 21.02 11.42 4.10 1.75
Accrued Liabilities, Current - - - 8.34 5.34
Financial Instruments - - - - -
Notes Payable, Current NO - - - - -
Other Liabilities, Current 49.09 479.85 357.58 12.21 4.47
Taxes Payable - - - - -
Deferred Liability and Revenue - - - - -
Discontinued Operation, Liabilities, Current - - - - -
OperatingLeaseLiabilityNoncurrent 39.94 47.95 37.07 9.81 -
Operating Lease Liability Current 5.24 2.65 3.01 5.50 -
Total Current Liabilities 58.28 500.86 369.00 24.65 11.56
Long-term debt 104.59 - - - -
Capital Lease and Other - - - - -
Convertible Notes Payable, Noncurrent LO 576.95 - - - -
Total Long-term Debt 681.54 - - - -
Financial Instruments, Insurance, Noncurrent - - - - -
Employee Benefit Plans, Noncurrent - - - - -
Deferred credits, Noncurrent - - - - -
Accrued Income Taxes, Noncurrent - - - - -
Discontinued Operation, Liabilities, Noncurrent - - - - -
Other liabilities, Noncurrent 350.57 311.32 343.83 9.81 10.89
Total Liabilities 1,090.39 812.18 712.82 34.47 22.44
SHAREHOLDER'S EQUITY
Common Stock Value 0.07 0.04 0.04 0.01 0.01
Additional Paid In Capital Common Stock 2,374.62 1,930.94 1,719.70 872.08 782.97
Retained Earnings / Accumulated Deficit -2,961.68 -2,378.49 -1,961.92 -754.57 -662.19
Defined Benefit Plan and Other 118.77 21.64 - - -
Other Equity -118.76 -21.45 0.00 -0.12 -0.11
Noncontrolling interests & other 1.05 -2.49 -1.74 - -
Total Stockholder's Equity -585.94 -449.82 -243.91 117.39 120.68
Liabilities & Stockholder's Equity 504.45 362.36 468.91 151.86 143.12






Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com